(Research Report) “The result of the Study of the Social Economic Burden of Chronic Obstructive Pulmonary Disease (COPD)”
date : 1/16/2014
Chronic Obstructive Pulmonary Disease (COPD) is expected to become the third leading cause of death in the world in 2030 by the estimation of the World Health Organization (WHO). In Japan, the mortality rate is also expected to increase. Worsening of quality of life (QOL) is believed to have an implication on the productivity of the workers with COPD. However, we never really have a good grip of how much producitivity lost with the different degrees of COPD symtoms, nor we have a good understanding of the social economical burden of COPD in Japan. This study aims to clarify 1. The actual lost of productivity in COPD patients, 2. The affects on QOL, and 3. The prevalence of potential COPD patients.
1. QOL decreased by the level of severity.
Severity of COPD is classified as non-COPD, potential COPD, and diagnosed COPD in this study. The QOL scores of the participants showed that the QOL significantly decreased by severity of COPD. The results remained the same after adjusted with the confounding factors for age and sex.
2. The lost of time in COPD patients is significantly more than the healhty people.
The lost of time in COPD patients is 4.1 hr significantly longer than the health participants (15.8 hr vs 19.9 hr). The overtime loss due to COPD was estimated to be about 470,000 yen per person per year. Medical cost provided by the medical insurance is added up to another 60,000 yen per person per year.
3. The medical cost and production lost of COPD patients is at least 2,000 billion yen.
It is shown that the medical cost on COPD patients is 1.584 billion yen, cost of production lost is 496 billion yen, adding up to a total cost of 2.080 billion yen lost. It is believed that the total cost of lost is much more larger after incorporating the lost outside the work and the productivity lost of the potential COPD.
《Future Policy Direction》
1. Establishment of a system for early dection and treatment of COPD
Screening by simple spirometer and questionnaire is effective in the early detection of persons with suspected COPD, however it is not regularly used because it is not an essential item in the health examination. Future policy needs to establish a system for early dection and treatment of COPD, so that we can have a more effective health care screening.
2. Train more specialists to enable proper care provision system and treatment
Intervention by health professionals is essential to develop a proper care provision system and the treatment of COPD. However, there are very few respiratory specialists nor certified COPD nurses compared to other fields in Japan. With the increase demands in COPD care, it is essential to train more specialists and nurses in the relevent field.
3. Promotion of collaboration system for the relevant stakeholders
Following the example of diabetes, where the academic and medical association join hands in diabetes management through promoting dialogues and equipping medical doctors for diabetes management, COPD had also made its move in recent years such as the establishment of “Japan COPD management conference”. We expect to build a mechanism that tackles local issues through such collaboration of relevent stakeholders.
4. Promotion of populational awareness
The level of populational awareness of the word COPD is hope to increased from 25% to 80% through the promotion of Healthy Japan 21 (Second). The word of COPD needs to have a wide recognition as it helps to lead to early dection of the disease. Also, it is necessary to have a right perspective on COPD among the health care workers and relevant health sectors.
Top Research & Recommendations Posts
- [Policy Recommendations] Joint Statement “Protecting the Health of Both the Planet and People — A Japan-Model Planetary Health Strategy to Turn the Climate Crisis into an Opportunity for Health, the Economy, and Growth” (June 24, 2026)
- [Research Report] Energy Conservation and Greenhouse Gas Emissions Reduction in Healthcare Facilities: Case Studies from New Construction and Facility Renewal (March 16, 2026)
- [Recommendations] Strengthening Epidemiology Education in the Veterinary Field for the One Health Era (June 19, 2026)
- [Activity Report] HGPI Contributed to the Development of the Civil 7 (C7) Global Health Working Group’s Climate and Health Thematic Brief for the G7 (June 25, 2026)
- [Research Report] AMR Policy Update #6: The New Global Action Plan on AMR (Part 1)
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Research Report] AMR Policy Update #8: Fostering AMR-Conscious Youth: The Antibiotic Smart Sweden Certificate Program and its Implications for Early Childhood Education (July 1, 2026)
- [Research Report] Perceptions, Knowledge, Actions and Perspectives of Healthcare Organizations in Japan in Relation to Climate Change and Health: A Cross-Sectional Study (November 13, 2025)
- [Announcement] HGPI Joins the UHC2030 Task Force for the 2027 UN High-Level Meeting on UHC (July 6, 2026)
- [Research Report] AMR Policy Update #7: The New Global Action Plan on AMR (Part 2)
Featured Posts
-
2026-06-19
[Recommendations] Strengthening Epidemiology Education in the Veterinary Field for the One Health Era (June 19, 2026)
-
2026-07-02
[Research Report] Medical Practitioner Interviews on the Current State and Issues for Interdepartmental Collaboration in Clinical Practice for Chronic Kidney Disease (June 30, 2026)
-
2026-07-21
[Announcement] Announcement of the 2nd Kiyoshi Kurokawa Award Recipient
-
2026-07-22
[Registration Open] Second Session of the Planetary Health Academy (Starts September 2026)



